Unbiased Analysis of Today's Healthcare Issues
If you are interested in working with me at Precision Health Economics, please apple here. A job description is below. Associate Research Scientist – Health Policy Location: Los Angeles, California US Job Id: 1357 Los Angeles, California US Work From Home Available:No Exempt,Regular Full-time Division:Precision Value & Health Business Unit:Precision Health Economics Who we…
Many of my readers will know what adverse selection is, but to reiterate, adverse selection occurs in health insurance markets when sicker patients decide to choose specific types of plans. If a health insurer believes they will have a representative sample of enrollees but instead they have a disproportionate share of sick individuals, they will…
Drug prices under Trump. Competition in HCV treatment. Shale gas drilling and infant health. Winning worse than losing. Manski responds.
At first glance, spending a lot of money at the end of people’s life doesn’t make sense. From an economics perspective, the “return on investment” is less, since one may have been able to spend the same money earlier in life to prolong survival. Further, for any given treatment, these treatments are often less effective…
Do most employees with HDHP have employer funded HSAs? Are cardiovascular drugs providing high value? Cash transfers→ better health? “We need to be innovative with our care as long as we fervently believe we can do it safely,” Raj of the NHS.
How long do sick kids in low-income countries get to spent with their physician at a doctor’s visit? A paper by Kruk et al. (2018) surveys health facilities in Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Tanzania, and Uganda to find out. The answer is that patient’s do not get much time at all. The median…
Physicians as debt collectors. U.S. health care administrative costs. Cross-subsidies. A small donation. Most feared CEO in health care.
Value is a matter of perspective, and no patient is average. As stakeholders across healthcare struggle with and refine the process of determining value, differing perspectives will trigger fierce debate, with some arguing that cost-effectiveness analysis should never have a place in a value-based health system. But it would be a mistake to completely disregard…
Moral hazard and HIV treatment. Physicians are a rate limiting factor. The biggest supreme court decisions of 2018. FDA=Federal Drug Administration Is marijuana addiction rising in Colorado?
Will 1 in 4 of Earthlings soon be obese? How quickly do patients need physicians follow-ups after hospitalization? Is there adverse selection in California’s individual health insurance market? Does continuity of care matter? An example in home health. Success at BC/BS value-based care program?